OtherCardiovascular
A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters
Koutaro Tsunemi, Shinji Takai, Masayoshi Nishimoto, Denan Jin, Masato Sakaguchi, Atsushi Yuda, Shinjiro Sasaki and Mizuo Miyazaki
Journal of Pharmacology and Experimental Therapeutics February 11, 2004, DOI: https://doi.org/10.1124/jpet.103.063974
Koutaro Tsunemi
Shinji Takai
Masayoshi Nishimoto
Denan Jin
Masato Sakaguchi
Atsushi Yuda
Shinjiro Sasaki
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherCardiovascular
A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters
Koutaro Tsunemi, Shinji Takai, Masayoshi Nishimoto, Denan Jin, Masato Sakaguchi, Atsushi Yuda, Shinjiro Sasaki and Mizuo Miyazaki
Journal of Pharmacology and Experimental Therapeutics February 11, 2004, DOI: https://doi.org/10.1124/jpet.103.063974
OtherCardiovascular
A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters
Koutaro Tsunemi, Shinji Takai, Masayoshi Nishimoto, Denan Jin, Masato Sakaguchi, Atsushi Yuda, Shinjiro Sasaki and Mizuo Miyazaki
Journal of Pharmacology and Experimental Therapeutics February 11, 2004, DOI: https://doi.org/10.1124/jpet.103.063974
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement